参考文献/References:
[1] CUNNINGHAM J W, CLAGGETT B L, O’MEARA E, et al. Effect of sacubitril/valsartan on biomarkers of extracellular matrix regulation in patients with HFpEF[J]. Journal of the American College of Cardiology, 2020, 76(5): 503-514.
[2] NAIR N. Epidemiology and pathogenesis of heart failure with preserved ejection fraction[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 531-540.
[3] GUO Hui, ZHANG Yongxin, LIAO Zifang, et al. MiR- 146a upregulates FOXP3 and suppresses inflammation by targeting HIPK3/STAT3 in allergic conjunctivitis[J]. Annals of Translational Medicine, 2022, 10(6): 344.
[4] 程璐, 时学昆, 张超, 等. miR-146a 调控PI3K/Akt 信号通路促进心力衰竭大鼠心肌细胞凋亡[J]. 生物 技术通讯, 2020, 31(3): 275-280. CHENG Lu, SHI Xuekun, ZHANG Chao, et al. MiR- 146a regulates PI3K/Akt signaling pathway and promotes cardiomyocyte apoptosis in rats with heart failure[J]. Letters in Biotechnology, 2020, 31(3): 275-280.
[5] 张文婧, 洪海波, 胡文倩, 等. 静脉血NT-proBNP 联 合miR-146a 对射血分数保留性心力衰竭诊断及预 后的影响[J]. 长寿, 2020, 1(12): 82. ZHANG Wenjing, HONG Haibo, HU Wenqian, et al. Effect of venous blood NT-proBNP combined with miR-146a on diagnosis and prognosis of heart failure with ejection fraction retention[J]. Longevity, 2020,1(12): 82.
[6] LI Yatan, ZHAO Jun, SHAO Hua, et al. Preventive effect of total flavonoids of Trollius altaicus on a chronic obstructive pulmonary disease rat model based on the TLR4/NF-κB pathway[J]. Annals of Translational Medicine, 2022, 10(4): 222.
[7] 中华医学会心血管病学分会心力衰竭学组, 中国医 师协会心力衰竭专业委员会, 中华心血管病杂志编 辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789. Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure 2018 [J]. Chinese Journal of Cardiology, 2018, 46(10): 760-789.
[8] UPADHYA B, KITZMAN D W. Heart failure with preserved ejection fraction: New approaches to diagnosis and management[J]. Clinical Cardiology,2020, 43(2): 145-155.
[9] 高婉琴, 李小丹, 杨朋康, 等. 血清Galectin-3 和sST2 水平检测用于保留射血分数心力衰竭的生物标记物 的研究[J]. 现代检验医学杂志, 2019, 34(6): 54-59. GAO Wanqin, LI Xiaodan, YANG Pengkang, et al. Study on Galectin-2 and sST2 used as biomarker for heart faliure patient with preserved ejection fraction[J]. Journal of Modern Laboratory Medicine, 2019, 34(6): 54-59.
[10] ZHANG Bei, MAO Shanyong, LIU Xingde, et al. MiR- 125b inhibits cardiomyocyte apoptosis by targeting BAK1 in heart failure[J]. Molecular Medicine, 2021,27(1): 72.
[11] 杨萍, 代天, 张苏川. 慢性收缩性心力衰竭患者血清 miR-129 表达与心功能的关系[J]. 中国动脉硬化杂 志, 2021, 29(4): 312-316. YANG Ping, DAI Tian, ZHANG Suchuan. The relationship between serum miR-129 expression and cardiac function in patients with chronic systolic heart failure [J]. Chinese Journal of Arteriosclerosis, 2021,29(4): 312-316.
[12] LIU Wei, WU Yuanhao, ZHANG Lei, et al. MicroRNA- 146a suppresses rheumatoid arthritis fibroblast-like synoviocytes proliferation and inflammatory responses by inhibiting the TLR4/NF-kB signaling[J]. Oncotarget,2018, 9(35): 23944-23959.
[13] 牛君义, 陈凤英, 狄祥龙, 等. 血清miR-146a 与 miR-34a 表达水平对ACS 冠脉病变及预后评估价值 [J]. 临床心血管病杂志, 2020, 36(9): 815-818. NIU Junyi, CHEN Fengying, DI Xianglong, et al. Clinical value of serum levels of miR-146a and miR- 34a to the severity and prognosis in patients with acute coronary syndrome [J]. Journal of Clinical Cardiology,2020, 36(9): 815-818.
[14] HE Junjie, LU Ying, SONG Xiaozheng, et al. Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats[J]. Bioscience Reports, 2019,39(12): BSR20191732.
[15] 杨柳, 党永康, 乌兰, 等. miR-146a-5p 靶向IRAK-1 调控DVT 患者内皮祖细胞的增殖及炎症[J]. 重庆医 学, 2021, 50(17): 2906-2911. YANG Liu, DANG Yongkang, WU Lan, et al. MiR- 146a-5p regulating proliferation and inflammation of endothelial progenitor cells of DVT patients by targeting IRAK-1 [J]. Chongqing Medicine, 2021,50(17): 2906-2911.
[16] HE Liang, WANG Zhuoran, ZHOU Rui, et al. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway[J]. Biomedicine & Pharmacotherapy, 2021, 133: 110993.
[17] 朱明娜, 张丽华, 蒋友旭, 等. 高血压患者动态动脉 硬化指数与射血分数保留性心力衰竭严重程度的 相关性研究[J]. 中国全科医学, 2021, 24(20): 2568- 2572. ZHU Mingna, ZHANG Lihua, JIANG Youxu, et al. Correlation between ambulatory arterial stiffness index and severity of heart failure with preserved ejection fraction in patients with hypertension[J]. Chinese General Practice, 2021, 24(20): 2568-2572.
[18] 李俐, 肖俊会, 毕健成, 等. 老年慢性心力衰竭患者 血浆BNP,TNF-α 和血清cTnI 水平与心室重构 指标及心功能的相关性[J]. 中国老年学杂志, 2019,39(5): 1031-1034. LI Li, XIAO Junhui, BI Jiancheng, et al. Correlation of plasma BNP,TNF-α and serum cTnI levels with ventricular remodeling index and cardiac function in elderly patients with chronic heart failure[J]. Chinese Journal of Gerontology, 2019, 39(5): 1031-1034.
[19] 王玉华, 佟士骅, 居海宁, 等. 有氧康复运动对慢性 心力衰竭患者心室重构及血管内皮功能的影响[J]. 现代生物医学进展, 2018, 18(11): 2118-2121. WANG Yuhua, TONG Shihua, JU Haining, et al. Influence of aerobic rehabilitation exercise on the ventricular remodeling and endothelial function of patients with chronic cardiac failure[J]. Progress in Modern Biomedicine, 2018, 18(11): 2118-2121.